Immunovia AB (LTS:0G8X) Total Liabilities : kr21.39 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Immunovia AB Total Liabilities?

Immunovia AB's Total Liabilities for the quarter that ended in Dec. 2024 was kr21.39 Mil.

Immunovia AB's quarterly Total Liabilities declined from Jun. 2024 (kr38.56 Mil) to Sep. 2024 (kr24.50 Mil) and declined from Sep. 2024 (kr24.50 Mil) to Dec. 2024 (kr21.39 Mil).

Immunovia AB's annual Total Liabilities declined from Dec. 2022 (kr56.79 Mil) to Dec. 2023 (kr31.69 Mil) and declined from Dec. 2023 (kr31.69 Mil) to Dec. 2024 (kr21.39 Mil).

Immunovia AB Total Liabilities Historical Data

The historical data trend for Immunovia AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB Total Liabilities Chart

Immunovia AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

61.78

59.91

56.79

31.69

21.39

Immunovia AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															31.69	27.33	38.56	24.50	21.39

Immunovia AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Immunovia AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.685	+	(0	+	5.708
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	21.39

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	33.042	-	11.649
	=	21.39

Immunovia AB's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.685	+	(0	+	5.708
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	21.39

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	33.042	-	11.649
	=	21.39

Immunovia AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Immunovia AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunovia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (LTS:0G8X) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

IMMNOV:Sweden 1YR:Germany

Address

Medicon Village, Scheelevagen 8, Lund, SWE, 223 63

Website

https://www.immunovia.com

Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The company is currently developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer.

Immunovia AB Headlines

No Headlines